Nuveen Asset Management LLC Sells 3,954,272 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Nuveen Asset Management LLC cut its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 67.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,915,999 shares of the health services provider's stock after selling 3,954,272 shares during the period. Nuveen Asset Management LLC owned 1.11% of Teladoc Health worth $17,416,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC bought a new position in Teladoc Health during the fourth quarter valued at approximately $29,000. Lindbrook Capital LLC raised its holdings in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after acquiring an additional 1,612 shares in the last quarter. Sterling Capital Management LLC raised its holdings in shares of Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after acquiring an additional 4,101 shares in the last quarter. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Teladoc Health during the 4th quarter valued at approximately $60,000. Finally, Generali Investments Management Co LLC purchased a new position in shares of Teladoc Health in the fourth quarter valued at $64,000. 76.82% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of recent research reports. Piper Sandler decreased their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Stifel Nicolaus decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Thursday, May 1st. Truist Financial lowered their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday. Wells Fargo & Company dropped their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Finally, The Goldman Sachs Group decreased their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and a consensus target price of $9.60.

Teladoc Health Trading Down 1.5%

TDOC stock traded down $0.11 during midday trading on Wednesday, reaching $6.98. The company's stock had a trading volume of 2,061,317 shares, compared to its average volume of 6,713,203. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -1.21 and a beta of 1.82. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The stock has a fifty day simple moving average of $7.37 and a two-hundred day simple moving average of $9.26. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.58% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.